Pulmonology - Jun 6, 2023 - Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer

Can't see this email? View it online

	Pulmonology
	The latest pulmonology news from News Medical

	Stopping treatment at two years does not seem to compromise overall survival in patients with advanced lung cancer Over the past decade, the approval of immune checkpoint inhibitors has revolutionized treatment for patients with advanced lung cancer, helping many live longer lives and improving overall survival for the disease.

	Study explores the link between sleep apnea and brain volume Studies have shown that sleep apnea is related to an increased risk of dementia. A new study looks at the relationship between sleep apnea and brain volume.

			Unraveling the complexity of 'Long-COVID' and its impact on breathing More than a third of COVID-19 patients experience long-lasting symptoms, known as post-COVID-19 condition or long COVID, with breathlessness being a commonly reported symptom. Pulmonary complications, such as fibrosis and thromboembolic disease, require careful assessment, and non-pharmacological interventions like pulmonary rehabilitation can help manage breathlessness.

			Spike in childhood human metapneumovirus infections in Western Australia linked to reduced COVID-19 measures Researchers investigated the prevalence of human metapneumovirus through 2020 considering the implementation of NPIs due to the COVID-19 pandemic.

			Mice study shows how obstructive sleep apnea may affect gene activity throughout the day The low blood oxygen levels of obstructive sleep apnea cause widespread changes in gene activity throughout the day, according to a new study in the open-access journal PLOS Biology by David Smith of Cincinnati Children's Hospital Medical Center, US, and colleagues.

	Aggressive lung pathogen may not be prone to person-to-person transmission A little-known bacterium -; a distant cousin of the microbes that cause tuberculosis and leprosy -; is emerging as a public health threat capable of causing severe lung infections among vulnerable populations, those with compromised immunity or reduced lung function.

	Study measures the annual prevalence of nontuberculous mycobacterial lung disease in Ontario, Canada Researchers determined the prevalence of nontuberculous mycobacterial pulmonary disease (NTM-PD) in 2020.

	Real-world management and outcomes of U.S. patients treated with BpaL for rifampin-resistant tuberculosis Researchers reported on the treatment of rifampin-resistant tuberculosis in the United States using the FDA approved bedaquiline, pretomanid, and linezolid (BPaL) therapy.

	Babies experiencing hypoxia due to sleep apnea tend to develop hypertension in adulthood Newborn babies who experience low levels of oxygen in their body tissues (hypoxia) due to sleep apnea, for example, tend to develop respiratory problems and hypertension (high blood pressure) in adulthood, and these problems may persist for the rest of their lives.

	University of Louisville researchers receive $5.8 million to prevent immune system dysregulation Researchers at the University of Louisville have received $5.8 million in two grants from the National Institutes of Health to expand their work to better understand and prevent immune system dysregulation responsible for acute respiratory distress, the condition responsible for serious illness and death in some COVID-19 patients.

Website: www.news-medical.net

Email: [email protected]

Telephone: +44 (0)161 457 7150

AZoNetwork UK Ltd.
NEO, 4th Floor
9 Charlotte Street, Manchester
M1 4ET, UK

Why did you receive this email?
You recently requested related information from us and asked to be notified of additional information.

Not interested anymore?
Unsubscribe or
Update Your Newsletter Subscriptions